Research for the mechanisms of anabolic action of parathyroid hormone(PTH) on bone and interaction between PTH and estrogen in osteoblasts

甲状旁腺激素(PTH)对骨的合成代谢作用机制及成骨细胞中PTH与雌激素相互作用的研究

基本信息

  • 批准号:
    14571064
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

Although several studies indicated that parathyroid hormone (PTH) exerted anabolic action on bone and estrogen augmented its anabolic action on bone, their precise mechanisms have been unknown. TGFβ stimulates bone formation in vivo and regulates the transcriptional response of the target genes through the two receptor -regulated Smads, Smad2 and Smad3. Our study revealed that Smad3 was an important molecule for bone formation. Next, we examined the effects of PTH on Smad3 and its physiological significance in osteoblasts. PTH promoted Smad3 mRNA and protein levels though PKA and PKC pathways in mouse osteoblastic MC3T3-E1 cells and rat osteoblastic UMR-106 cells. We, next, examined anti-apoptotic effects of PTH and Smad3. Pretreatment with PTH or overexpression of Smad3 decreased the number of apoptotic cells induced by dexamethasone or etoposide. Moreover, a dominant negative mutant, Smad3deltaC, abrogated PTH-induced anti-apoptotic effects. On the other hand, PTH augmented TGFβ-indu … More ced transcriptional activity of Smad3. Furtheremore, PTH enhanced TGFβ-induced production of type1collagen. These observations indicate that PTH amplified the anabolic effects of TGFβ by accelerating the transcriptional activity of Smad3. We first demonstrated that PTH-Smad3 axis exerts anti-apoptotic effects and reinforces the anabolic action by TGFβ in osteoblasts. There is recent evidence about the importance of Wnt signaling in bone formation and we obtained data about stimulatory effects of PTH and Smad3 overexpression on β-catenin expression in osteoblasats. Hence, PTH-Smad-3 axis would be involved in bone anabolic action of PTH. As for studies about the interaction between PTH and estrogen in osteoblasts, estrogen attenuated PTH-induced inhibition of osteoblast proliferation and PTH stimulated osteoblast function in the presence of estrogen pretreatment in human osteoblastic SaOS-2 cells. And, IGF-I and/or IGF-binding protein-5 were involved in the estrogen-induced modulation of PTH action on osteoblast proliferation and function. Less
虽然已有研究表明甲状旁腺激素(PTH)对骨的合成代谢作用,雌激素对骨的合成代谢作用增强,但其确切的作用机制尚不清楚。转化生长因子β通过Smad2和Smad3两种受体调节的Smad2和Smad3在体内刺激骨形成并调节靶基因的转录反应。我们的研究表明,Smad3是骨形成的重要分子。接下来,我们研究了PTH对Smad3的影响及其在成骨细胞中的生理意义。PTH通过PKA和PKC途径促进小鼠成骨细胞MC3T3-E1和大鼠成骨细胞UMR-106中Smad3基因和蛋白的表达。接下来,我们研究了甲状旁腺素和Smad3的抗细胞凋亡作用。甲状旁腺素或过表达Smad3可减少地塞米松或依托泊苷诱导的细胞凋亡。此外,显性负性突变体Smad3deltaC取消了PTH诱导的抗细胞凋亡作用。另一方面,甲状旁腺激素增加转化生长因子β-INDU…Smad3转录活性增强。此外,甲状旁腺激素还能促进转化生长因子β诱导的I型胶原的产生。这些观察结果表明,甲状旁腺素通过促进Smad3的转录活性而增强了转化生长因子β的合成代谢作用。我们首次证实甲状旁腺激素-Smad3轴在成骨细胞中发挥抗凋亡作用,并增强转化生长因子β的合成代谢作用。最近有证据表明Wnt信号在骨形成中的重要性,我们获得了甲状旁腺激素和Smad3过表达对成骨细胞β-catenin表达的刺激作用的数据。因此,PTH-Smad-3轴可能参与了PTH的骨合成代谢作用。在成骨细胞中甲状旁腺激素与雌激素相互作用的研究中,雌激素减弱了甲状旁腺素对人成骨细胞SAOS-2细胞增殖的抑制作用和雌激素对成骨细胞功能的刺激作用。IGF-I和/或IGF结合蛋白-5参与了雌激素诱导的甲状旁腺素对成骨细胞增殖和功能的调节作用。较少

项目成果

期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sowa H: "Activations of ERK1/2 and JNK by TGFβ Negatively Regulate Smad3-induced Alkaline Phosphatase Activity and Mineralization in Mouse Osteoblastic Cells"J Biol Chem. 277. 36027-36031 (2002)
Sowa H:“TGFβ 激活 ERK1/2 和 JNK 负调节小鼠成骨细胞中 Smad3 诱导的碱性磷酸酶活性和矿化”J Biol Chem. 277. 36027-36031 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sowa T, Kaji H, Yamaguchi T, Sugimoto T, Chihara K.: "Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells."Bone Miner Res. 17. 1190-1199 (2002)
Sowa T、Kaji H、Yamaguchi T、Sugimoto T、Chihara K.:“Smad3 促进成骨细胞 MC3T3-E1 细胞的碱性磷酸酶活性和矿化。”Bone Miner Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sowa H: "Inactivation of menin, the product of the multiple endocrine neoplasia type1(MEN1) gene, inhibits the commitment of multipotential"J Biol Chem. 278. 21058-21069 (2003)
Sowa H:“多发性内分泌肿瘤 1 型 (MEN1) 基因产物 menin 的失活会抑制多潜能的发挥”J Biol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugimoto T, Kaji H, Nakaoka D, Yamauchi M, Yano S, Sugishita T, Baylink D, Mohan S, Chihara T.: "Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly osteoporotic women."Eur J Endocrinol. 147-3. 339-348 (2002)
Sugimoto T、Kaji H、Nakaoka D、Yamauchi M、Yano S、Sugishita T、Baylink D、Mohan S、Chihara T.:“低剂量重组人生长激素对老年骨质疏松女性骨代谢的影响。”Eur J
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Jonsson KB: "Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia"N Engl J Med. 348・17. 1656-1663 (2003)
Jonsson KB:“致癌性骨软化症和 X 连锁低磷血症中的成纤维细胞生长因子 23”N Engl J Med 348・17(2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUGIMOTO Toshitsugu其他文献

SUGIMOTO Toshitsugu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUGIMOTO Toshitsugu', 18)}}的其他基金

Elucidation of bone formation signal aimed at the development of medical treatment of osteoporosis induced by deterioration of bone formation
阐明骨形成信号,旨在开发骨形成恶化引起的骨质疏松症的药物治疗
  • 批准号:
    22590656
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research for the elucidation of bone formation signals applied to the development of bone-forming agents
阐明骨形成信号的研究应用于骨形成剂的开发
  • 批准号:
    18591025
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research for the role of calcium-sensing receptor in parathyroid gland and bone
甲状旁腺和骨中钙敏感受体的作用研究
  • 批准号:
    12671087
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research for the mechanisms of anabolic action of parathyroid hormone (PTH) and interaction between PTH and estrogen
甲状旁腺激素(PTH)合成代谢作用机制及PTH与雌激素相互作用的研究
  • 批准号:
    09671060
  • 财政年份:
    1997
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research for role of bone morphogenetic protein in the differentiation and activation of osteoclast and osteoblast
骨形态发生蛋白在破骨细胞和成骨细胞分化和活化中的作用研究
  • 批准号:
    07671136
  • 财政年份:
    1995
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reseach for cell-cell communication in bone remodeling and differentiation of osteoblast and osteoclast
骨重塑及成骨细胞和破骨细胞分化中细胞间通讯的研究
  • 批准号:
    04671479
  • 财政年份:
    1992
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Estrogen/NDRG2/Na+/K+-ATPase调控通路在唾液生成和雌激素缺乏诱发口干症中的作用研究
  • 批准号:
    81100764
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechanisms of estrogen receptor ligand signaling
雌激素受体配体信号传导机制
  • 批准号:
    10681785
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Manipulating normal estrogen physiology as a therapeutic approach in cancer
操纵正常雌激素生理学作为癌症的治疗方法
  • 批准号:
    10561945
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Estrogen modulation of the lateral habenula and its ability to inhibit midbrain dopamine neurons
雌激素对外侧缰核的调节及其抑制中脑多巴胺神经元的能力
  • 批准号:
    10588333
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Research on safety and efficacy evaluation focusing on estrogen-like action of health food materials and components
以保健食品原料及成分雌激素样作用为重点的安全性和功效评价研究
  • 批准号:
    23K10974
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of action of antiestrogens in breast cancer: roles of ubiquitin-like modifications in transcriptional inactivation of Estrogen Receptor alpha.
抗雌激素在乳腺癌中的作用机制:泛素样修饰在雌激素受体α转录失活中的作用。
  • 批准号:
    480045
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Estrogen receptor signaling, inflammation and ozone toxicity
雌激素受体信号传导、炎症和臭氧毒性
  • 批准号:
    10775945
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
  • 批准号:
    10607151
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer
探索雌激素受体阴性乳腺癌免疫预防的新策略
  • 批准号:
    10583390
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma
开发用于治疗胶质母细胞瘤的有效雌激素受体β激动剂
  • 批准号:
    10594832
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了